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Abstract	
Psychosocial treatments for chronic pain conditions, such as Acceptance and Commitment 
Therapy (ACT), have highlighted minimizing pain avoidance behaviors and increasing 
engagement in valued activities as key treatment targets. In terms of salient processes 
within ACT, committed action is considered essential to the pursuit of a meaningful life, as 
it entails a flexible persistence over time in living consistently with one’s values.  To date, 
however, only one study has examined the association between measures of committed 
action and important aspects of pain-related functioning. The purpose of the present study 
was to analyze the reliability of the Committed Action Questionnaire (CAQ) in a sample of 
149 chronic pain patients, perform a confirmatory analysis of its factor structure, and 
examine how CAQ scores uniquely account for variance in functioning. Confirmatory factor 
analyses provided support for a two-factor model, and regression analyses, which 
examined the cross-sectional direct effects of the two subscales on health-related 
functioning, indicated that the CAQ accounted for significant variance in functioning after 
controlling for relevant covariates. Overall, these findings provide further support for the 
CAQ as a measure of adaptive functioning in those with longstanding pain. 
	
Perspective:	The article presents additional evidence for the reliability and validity of the 
Committed Action Questionnaire with chronic pain patients. Confirmatory factor analyses 
provided support for the two-factor model, with both subscales demonstrating significant 
associations with multiple facets of health- and pain-related functioning.	
	
Keywords: chronic pain; committed action; values; behavioral therapy; Acceptance and 
Commitment Therapy	
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Introduction	
The experience of pain is a complex phenomenon comprising multiple facets, 
including nociception, neurophysiology, learning history, and ongoing experience.12, 29 
Chronic pain is typically defined as pain lasting three months or longer 31 and encompasses 
a breadth of common and debilitating medical conditions. In contemporary medicine, 
chronic pain is typically treated from the biopsychosocial perspective which takes into 
account the breadth of factors that are believed to maintain pain over time.13, 14  With 
regard to treatment strategies focusing on the behavioral factors involved, a primary 
objective frequently involves altering behavior to reduce the adverse impact of pain on role 
functioning. In particular, decades of research have suggested that persistent pain 
avoidance strategies are problematic, especially when they are frequent, inflexible, and 
ineffective.22, 23, 36  Psychosocial interventions for chronic pain have thus traditionally 
emphasized the goal of decreasing pain avoidance.12, 36 
Contemporary developments within the cognitive-behavioral tradition have further 
highlighted the benefits of targeting increased engagement in behaviors consistent with 
values. In particular, enhanced engagement in valued activities is a hallmark feature of 
Acceptance and Commitment Therapy (ACT).16  Within ACT, values help bring into focus 
the longer-term outcomes considered part of a meaningful and fulfilling life. To date, data 
suggest that greater engagement in valued activities is associated with lower levels of 
disability and distress.20, 27, 28, 39, 40  Furthermore, outcome research indicates that it is 
possible to increase engagement in valued activities over the course of treatment and that 
the increases are associated with improved functioning.27, 38, 41  
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A central process involved in values-based action is conceptualized in ACT as 
committed action.16 Committed action is a present-oriented process that involves building 
up patterns of behavior that move an individual toward valued life directions. In other 
words, committed action takes place in the “here and now,” and is part of an actively 
chosen path taken in the service of underlying values. 16  Specific to ACT-based approaches 
to pain treatment, this process entails, for instance, facilitating a present-focused ability to 
identify persistent and problematic pain avoidance strategies and shift those efforts toward 
pursuing values and living a meaningful life. Committed action further requires 
maintaining a careful balance between persistence and flexibility, with a willingness to 
experience discomfort, such as increased pain, or initial failure when pursuing goals related 
to what matters most to an individual, and, on the other hand, goals that are repeatedly 
unmet may be abandoned.24, 25 
Although research indicates that ACT-based interventions for chronic pain generally 
lead to improved functioning,2 at present, the only instrument designed to measure 
committed action is the Committed Action Questionnaire (CAQ), the reliability of which 
was initially examined with 216 chronic pain patients.25  Results of the initial analyses 
indicated that the CAQ had good internal consistency and that committed action was 
significantly correlated with acceptance of chronic pain, another facet of the psychological 
flexibility model in ACT. Moreover, regression analyses demonstrated that the CAQ 
accounted for significant incremental variance over pain acceptance across multiple 
aspects of behavioral health.25 
Although the results from the initial study of the CAQ are promising, the utility of 
the CAQ requires additional empirical study, particularly in relation to both the 
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generalizability of its reliability and validity and its incremental utility beyond instruments 
that measure similar behaviors. The present study therefore sought to examine the 
psychometric properties of the CAQ and evaluate the two-factor structure via confirmatory 
factor analysis. Further, given that values-based action and committed action share 
conceptual overlap under the psychological flexibility model in ACT, an additional purpose 
was to examine incremental utility of CAQ scores in explaining functioning among pain 
patients presenting for treatment. Specifically, it was hypothesized that CAQ scores would 
account for significant variance in pain-related emotional and physical functioning, even 
after controlling for values-based action. 
Methods	
Participant	Characteristics 
	 Participants were 170 adults presenting for an assessment appointment at a specialty 
pain treatment service in the United Kingdom between March of 2011 and October of 2012.  
In terms of schooling, participants had an average of 13.9 years of education (SD = 10.1). 
Descriptively, most had either completed only the compulsory course of education (38%) 
or had dropped out prior to graduating (32%).  Most participants were White European 
(99%), female (62%), and married or cohabitating with a partner (67%), followed by those 
who were single (14%), divorced (12%), and widowed (7%).   The mean age was 53.6 
years (SD = 14.5). 
 The most commonly reported primary pain diagnoses were arthritis (27%) and 
fibromyalgia (24%), followed by herniated disk (9%) and degenerative disk disease (9%), 
sciatica or radiculopathy (8%), and spondylosis (5%).  Half of participants did not report a 
pain diagnosis, although all patients provided data on pain location, with 95% and 72% 
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specifying a primary and secondary pain location, respectively.  The most common primary 
pain location identified was lower back, lumbar spine, sacrum and/or coccyx (50%), 
followed by lower limbs (20%), full body (8%) and cervical region (8%).  Participants 
frequently identified limbs or shoulders (47%) as a secondary pain site.  Most participants 
were not working (66%), though 14% were working full time and 10% worked part time.  
Many were receiving some type of incapacity benefit or wage replacement (48%).  The 
average pain duration was 11.6 years (SD = 11.6; median = 7.3), and ranged from 0.25 to 
54.7 years. 
Sampling	Procedures	
 Data were collected from all participants at an assessment visit to initiate a course of 
treatment.  The collection of these data was approved by the regional Research Ethics 
Committee of the U.K.’s National Health Service.   
Sample	Size	and	Power	
 In order to guide the data analyses and provide information on observed power, a 
post-hoc analysis of achieved power was computed based on a multiple regression model 
with seven predictors designed to detect a small (f2=0.02), medium (f2=0.15) or large effect 
size (f2=0.35; Cohen, 1992) at an alpha of 0.05 and with a sample size of 149.  Based on 
analyses using G*Power version 3.1.6,9 achieved power was calculated at .403, .997, and 
.999 for a small, medium and large effect size, respectively, suggesting adequate power to 
detect medium and large, but not small, effects. 
Measures	
 Study participants were assessed at a single point in time with a battery of self-
report instruments.  In addition to completion of this battery, they also provided 
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information pertaining to demographics (i.e., age, gender, years of education/educational 
achievement) and pain-related medical information (i.e., pain duration, pain intensity, pain-
related medical visits, number of prescribed classes of analgesic medication). 
Self‐Report	Instruments 
British	Columbia	Major	Depression	Inventory	(BCMDI).		The BCMDI18 is a 16-
item instrument that assesses for the presence and severity of Major Depressive Disorder 
(MDD), according to the DSM-IV criteria.1 Questions are anchored to a 5-point Likert-type 
rating scale that measures severity (1, very	mild	problem, to 5, very	severe	problem).  Total 
scores (range 0-80) were calculated and higher scores reflect increased symptom severity. 
The BCMDI has demonstrated good psychometric properties and excellent sensitivity and 
specificity for MDD.18  The internal consistency of the BCMDI in the present sample was 
acceptable (Cronbach’s α = .89). 
 Chronic	Pain	Values	Inventory	(CPVI).			The CPVI28 measures level of importance 
and success in six broad areas of valued activity, which comprise family, intimate or close 
interpersonal relationships, friends, work, health, and personal growth or learning.  
Importance and success in each valued domain are evaluated separately on a scale ranging 
from 0 (not	at	all	important/successful) to 5 (extremely	important/successful), which allows 
for the calculation of values importance, values success and discrepancies between levels of 
reported importance and success.  The discrepancy subscale was used in the current study 
because of its relation to values-based action and thus its potential as a suitable covariate 
for the CAQ. This subscale was calculated by subtracting values importance from values 
success, such that lower numbers (in the negative direction) indicated higher levels of 
discrepancy. Prior research28 demonstrated that the CPVI has acceptable internal 
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consistency (Cronbach’s α = 0.89 for the six items of the discrepancy subscale in the 
present sample). 
Committed	Action	Questionnaire	(CAQ;	Appendix).		As noted,	the primary aim of 
this study was to evaluate the CAQ and expand upon the initial study examining this 
measure.25  The final version of the CAQ from the prior study included 18 items (reduced 
from the original set of 24), in which respondents were asked to report on the accuracy of 
each statement in relation to their current functioning, ranging from 0 (never	true) to 6 
(always	true).  An initial study of the CAQ supported its internal consistency and 
demonstrated that it was correlated with acceptance of chronic pain, another key 
component of psychological flexibility in ACT.25  The prior study explored the factor 
structure of the CAQ using a principal components analysis, which revealed two underlying 
factors.  The factor structure was interpreted based on the wording of the items, with the 
“positively worded” items subsumed by the first factor, and the “negatively worded” items 
falling under the second. Further, in this initial study, the CAQ explained a significant 
amount of variance in important areas of health-related functioning, above and beyond 
pain acceptance, which included depression, social functioning, and mental health. The 
internal consistency of the CAQ in the present sample was acceptable (Cronbach’s α = .91). 	
Sickness	Impact	Profile	(SIP).		The SIP4 includes 136 yes or no questions 
pertaining to health-related dysfunction.  The three dimension scores of the SIP were used 
in the present analyses, which comprise physical, psychosocial, and independence-related 
disability. All scores range from 0 to 1, and higher scores indicate greater health-related 
dysfunction.  Prior research has demonstrated the reliability and validity of the SIP in the 
COMMITTED ACTION IN CHRONIC PAIN 
 
9
context of chronic pain.37  The internal consistency of the SIP in the present sample was 
acceptable (Cronbach’s α = .95).	
Pain	Anxiety	Symptoms	Scale‐20	(PASS).		The PASS26 is a 20-item instrument that 
evaluates fear, anxiety and avoidance behaviors in the context of pain.  This measure is 
anchored to a frequency scale ranging from 0 (never) to 5 (always).  The PASS has 
demonstrated good reliability, validity, and utility in prior studies involving chronic pain 
populations.32   The internal consistency of the PASS in the present sample was acceptable 
(Cronbach’s α = .94).	
Analytic	Approach	
 Data	screen	and	item	analyses.		All CAQ item responses were examined for missing 
data, and participants who did not record a single response for this measure (n = 21) were 
eliminated, resulting in a final sample size of 149.  Bivariate correlations were then 
examined for evidence of collinearity as well as for ensuring convergent validity among the 
scale items.  Item pairs were considered for deletion if bivariate correlations exceeded r = 
.85, indicating collinearity.21  Next, item-total correlations were assessed, where any item 
with a correlation with the remaining scale items below r = .20 was considered for 
deletion.10  Finally, internal consistency and the distribution of responses by item to 
evaluate normality were examined.  
Factor	structure	and	regression	analyses.		Following data screening, structural 
equation modeling (SEM) techniques were used to examine the two-factor structure of the 
CAQ. Although the prior study by McCracken 25 explained the two factors as emanating 
from wording effects, this conclusion was not tested empirically and research indicates that 
wording effects may or may not contribute to the emergence of separate factors.11, 33  For 
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the present study, it was assumed that the two-factor solution indicated the presence of 
latent variables underlying the CAQ. Based on the item content, the subscales were labeled 
values	persistence (VP), defined as the capacity to persist in the pursuit of goals, particularly 
when obstacles arise, and non‐reactive	behavior (NB), which is characterized by avoiding 
behaviors inconsistent with pursuing what matters most to the individual (e.g. not 
abandoning goals prematurely). (Note: The indicators that comprise the second factor of 
the CAQ, non‐reactive	behavior, were “negatively worded” and reverse scored prior to the 
analysis. Thus, higher scores were considered as indicative of better functioning.)  
A confirmatory factor analysis (CFA) tested whether the items loaded onto the 
factors in a way that is consistent with the underlying theory of committed action in ACT.  
SEM was also implemented to test the associations between the two latent subscale 
variables and critical measures of functioning to explore the potential clinical utility in 
assessing committed action with chronic pain patients using the CAQ.  The purpose of the 
SEM techniques was to examine the meaningfulness of committed action through its 
relationship with salient variables in chronic pain treatment.   
The first step at this stage of the analyses involved specifying a measurement model 
where the individual items (indicators) of the CAQ were loaded onto their respective 
factors, as reported by McCracken 25  The CFA evaluated the degree of concordance 
between the variance-covariance matrix produced by the specified model (the population 
matrix) and the matrix derived from the present sample. This approach has several 
distinctions from exploratory factor analysis (EFA) techniques, such as principal 
components analysis, and was more appropriate for the present study. Methods of EFA are 
often used to discover the patterns in which items from a measure correlate with one 
COMMITTED ACTION IN CHRONIC PAIN 
 
11 
another in order to create subsets that are combined into factors and to delete the items 
that are least useful in explaining the latent variable of interest.34  As the name implies, EFA 
is exploratory in nature and particularly useful in measure development when there is not 
a clear hypothesis about the underlying factor structure.  In contrast, the goals of the 
present CFA included evaluating all of the items from the prior study and investigating the 
two-factor structure with the present sample. As a final analytic step, the utility of the CAQ 
factors in the statistical prediction of aspects of patient functioning was examined, 
including disability, depression, pain-related fear, and pain-related medical visits over the 
preceding three months. All analyses used the Mplus software package, version 7.3.30 
The hypothesized CFA model (Figure 1) with two correlated latent factors scaled 
with unit loading identification was tested with maximum likelihood estimation.  The latent 
factors were scaled by fixing the loading of the first item for each factor to 1, leaving a total 
of 136 freely estimated parameters, which resulted in an over-identified model with dfM = 
308. The adequacy of the CFA model was first evaluated using the chi-square statistic, 
which compares the fit between the sample covariance matrix and the population 
covariance matrix.  A non-statistically significant chi-square indicates good fit for a model 
overall 21.  Following the recommendations put forth by Jackson, Gillaspy, Purc-Stephenson 
19 the hypothesized model was also evaluated against a residual-based measure, in this 
case the root mean square error of approximation (RMSEA), as well as incremental fit 
measures, which included the comparative fit index (CFI) and Tucker-Lewis index (TLI). 
Established benchmarks suggest that an RMSEA < .05 and < .085 and CFI and TLI > .95 and 
> .90, characterize models with good fit and acceptable fit, respectively.17  The RMSEA 
hypothesis of close fit was also evaluated (H0: RMSEA ≤ 0.05). 
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 Missing data on the CAQ were present for 4.6% of all possible responses. In order to 
address these missing data, multiple imputation (MI) methods were used.  The use of MI, as 
well as full information maximum likelihood (FIML), has demonstrated superiority to 
single imputation methods, such as mean substitution or regression-based imputation, and 
is especially useful when data are assumed to be not missing completely at random. Under 
this assumption, MI and FIML will tend to produce more unbiased estimates than complete 
case analysis or single imputation methods.3  In the present study, MI was chosen over 
FIML because covariates were included in the analyses, and Mplus30 defaults to listwise 
deletion for individuals with data missing on covariates. Using MI involves only two steps 
in Mplus: 1) creating 20 datasets that included all variables in the present analyses with 
multiple imputed values for each missing data point and 2) deriving a pooled estimate from 
each database for calculating beta estimates, standard errors, and indices of fit.  In 
summary, although it is impossible to empirically evaluate the degree to which the would-
be values of missing data might be related to the variables of interest,3, 15 MI was conducted 
under the reasonable assumption that missing data in the sample for the present study may 
be related to measured variables in the analyses (e.g. pain intensity).  
Following the CFA, the regression component of the present analyses was 
implemented to examine whether the two latent variables of VP and NB that comprise the 
CAQ were significantly associated with measures of health-related functioning, even after 
accounting for relations with other relevant variables.  To accomplish this objective, a 
series of simultaneous linear regression equations were created, where each of seven 
aspects of health-related functioning, including physical, psychosocial, and independence-
related disability, as well as depression, pain anxiety, pain-related medical visits, and the 
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number of prescribed analgesic medications were regressed on specific background 
variables, the values discrepancy measure (CPVI) and the two factors of the CAQ.  
The regression analyses were completed in two steps, resulting in two sets of seven 
simultaneous regressions.  In the first set, the background variables in the regression 
analyses included sex, pain intensity, pain duration, and years of education, and were 
entered as covariates because of their hypothesized relationship with pain-related 
functioning.  The second set of regressions included these same background variables and 
added the values discrepancy scores of the CPVI, which was chosen as a covariate because 
of the theoretical similarity to committed action. Indeed, given that both committed action 
and values discrepancy (calculated as the difference between values importance and values 
success) are subsumed by the broader concept of values-based action,16 this analytic 
approach appeared to be a particularly conservative method of testing the unique variance 
accounted for by the CAQ. Further, as part of the more general goals of a measure 
development study, the present analyses were intended to test whether the CAQ 
demonstrated incremental validity in predicting salient measures of functioning above and 
beyond currently available instruments. It should also be noted that the psychological 
flexibility model of ACT offered another relevant covariate in the Chronic Pain Acceptance 
Questionnaire (CPAQ), a 20-item instrument that measures activity engagement and pain 
willingness in chronic pain. The CPAQ, however, has been tested previously as a covariate 
by McCracken,25 who found that CAQ and CPAQ scores were highly correlated and yet the 
CAQ still accounted for significant incremental variance explained in five of the six 
measures of functioning tested. 
The results of the regression analyses included standardized regression 
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coefficients, or betas, which indicate the association between the predictor variables and 
the outcome of interest in terms of standard deviation units. Betas were standardized using 
the variances of the continuous latent variables as well as the variances of the outcome and 
covariate variables. These analyses also involved the imputed datasets using MI, where the 
single regression coefficients reported in the final results (Table 2) were pooled across the 
20 datasets. 
Results	
Data	Screening	and	Item	Analysis	
As noted, the final sample size for the following analyses consisted of 149 
individuals.  The 18-item CAQ demonstrated good internal consistency (Cronbach’s α = .90) 
and corrected item-total correlations were all in the acceptable range (range	r	 = .40 to .75), 
with the exception of item 11 (r = .18),	I	get	stuck	doing	the	same	thing	over	and	over	even	if	
I	am	not	successful.  In accordance with the guideline to consider deleting any item with an 
item-total correlation below r = .2010, item 11 was dropped from all subsequent analyses, 
resulting in a 17-item scale.  The final 17-item scale performed similarly in terms of 
reliability (Cronbach’s α = .91).  Item-total statistics also indicated that the removal of any 
one item did not substantially impact Cronbach’s alpha, which ranged from α = .90 to .91.  
The skewness and kurtosis indices did not show any significant deviations from normality 
at the item level.  The results of the data screening also indicated an absence of collinearity, 
with all inter-item correlations falling below the recommended cutoff of r = .85.  
Factor	Structure	and	Regression	Analyses 
The overall results from the hypothesized CFA model (Figure 1) demonstrated 
reasonable fit for the hypothesized two-factor model, with factors labeled as values	
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persistence (VP) and non‐reactive	behavior (NB). The incremental fit indices, CFI = .903 and 
TLI = .875, and the RMSEA = .061 (90% CI [0.050, 0.072]) all indicated reasonable fit. 
Although the upper bound of the RMSEA confidence interval was less than .10, supporting a 
decision to reject the poor-fit hypothesis, the lower bound did span .05, which results in a 
rejection of the close-fit hypothesis (i.e., that fit was “worse than close”, p-value |RMSEA ≤ 
0.05| = .04).21 The chi-square statistic was also significant, χ²M (308) = 480.09, p	< 0.0001, 
an indicator of poor fit. Finally, the collinearity diagnostics did not reveal any problematic 
associations among the items, including the latent variables, given that all correlations 
were in the moderate range, there were no beta weights outside the range of -1.0 to 1.0, 
and the tolerances ranged from .24 to .88. An examination of the residuals [last step![] 
Although there were several indications of reasonable model fit, the modification 
indices suggested that one pair of items had shared variance not explained by the latent 
factor, and specifying the presence of this shared error variance in model specification 
would improve fit. This included items 15 (I	am	able	to	pursue	my	goals	both	when	this	feels	
easy	and	when	it	feels	difficult) and 16 (I	am	able	to	persist	in	what	I	am	doing	or	to	change	
what	I	am	doing	depending	on	what	helps	me	reach	my	goals). After examining the bivariate 
correlations, this result was unsurprising because items 15 and 16 had the highest degree 
of association among any of the item pairs (r	= .82). Given that this pair of items appeared 
to capture similar behaviors within a single latent factor, several additional analyses were 
conducted. Initially, two CFA models, the first excluding item 15 and the second item 16, 
were conducted to determine if fit improved. The resulting fit indices were highly 
concordant with the CFA including all items, thus we proceeded to investigate a model 
where the error terms of these two items were allowed to correlate. 
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The re-specified model, which included the correlated error term, was tested with 
maximum likelihood estimation. The latent factors were scaled by setting the latent 
variable variances to 1.0, leaving 137 parameters freely estimated, which resulted in an 
over-identified model with dfM = 307. The results of the incremental fit indices, CFI = .920 
and TLI = .896, were similar to the initial model and indicated reasonable fit. The RMSEA = 
.056 (90% CI [0.044, 0.067]) demonstrated an improvement over the baseline model, with 
the results indicating a rejection of the poor-fit hypothesis (upper bound < .10) as well as a 
failure to reject the close-fit hypothesis (p-value |RMSEA ≤ 0.05| = .019).5  Furthermore, 10 
of the 17 indicators in this model had more than 50% of their variance accounted for by 
their respective latent factor, which corresponds to a standardized factor loading ≥ .707, 
bolded in Table 1 (range R2 .19 to .76, all p’s < .001). The chi-square statistic, however, 
remained significant, χ²M(307) = 449.93, p	< 0.001, which was the sole indicator of poor fit 
in both models. Given that the other fit indices indicated at least adequate fit, it was decided 
that fit appeared reasonable. Internal consistency calculations provided further evidence of 
acceptable internal consistency, with Cronbach’s alpha for VP = .93 and for NB = .85.  The 
chi-square difference test suggested that the re-specified model represented a significant 
improvement over the first, Δχ2(1) = 30.16, p < .0001. 
 The regression analyses (Table 2) were constructed to examine the associations 
between the two latent factors that make up the CAQ subscales, VP and NB, and measures 
of health-related functioning, while also controlling for specific background variables.  
Analyses were conducted without the values discrepancy (CPVI) measure (SEM Model 1) 
and with the values discrepancy (CPVI) measure (SEM Model 2), in order to determine the 
unique predictive ability of the CAQ subscales above and beyond an existing measure of 
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values-based action.   
 In SEM Model 1 (without the CPVI), both factors of the CAQ were significantly 
associated with psychosocial, physical, and independence-related disability, as well as with 
depression and pain distress (range β	-.52 to -19, all p’s < .05). In addition, the NB factor 
had a significant direct effect on pain anxiety (β = -.48, p < .001) and VP had a significant 
effect on the number of pain-related medical visits (β = -.27, p = .011).  The background 
variables were weakly associated with the measures of functioning.  In particular, pain 
intensity was significantly associated with pain distress (β = .49, p < .001) and pain anxiety 
(β = .18, p = .024), and pain duration was significantly associated with physical disability (β 
= .35, p < .001) and independence disability (β = .28, p < .001). The results did not reveal 
any other significant associations between background variables and pain-related 
functioning (range β	-.15 to .12, all p’s n.s.).  
 In SEM Model 2 (with the CPVI included), the pattern of results with regard to the 
background variables was largely unchanged (see Table 2).  Of primary interest were the 
results pertaining to the associations between the two CAQ factors and health-related 
functioning, after accounting for a theoretically similar measure in values discrepancy (the 
CPVI).  Results indicated significant associations between all measures of health-related 
functioning and at least one factor of the CAQ.  The NB factor, in particular, was 
significantly associated with the psychosocial (β = -.41, p < .001), physical (β = -.21, p = 
.038), and independence-related (β = -.27, p = .004) subscales of the SIP, and was also 
significantly associated with depression (β = -.53, p	< .001), pain anxiety (β = -.47, p	< .001), 
and pain distress (β = -.21, p	= .017).  These findings were all in the expected direction, such 
that greater NB scores were associated with decreased scores on the dependent measures. 
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In addition, the VP factor was also significantly associated with pain distress (β = -.22, p	= 
.011) and number of pain-related medical visits (β = -.23, p = .039).  Taken together, the 
results support the relevance of CAQ factor scores for multiple facets of patient functioning. 
 Also in SEM Model 2, the CPVI was significantly associated with physical, 
psychological, and independence-related disability, as well as with depression and pain 
anxiety (range β	-.43 to -.21, all p’s < .01).  The CPVI was not significantly associated with 
the number of analgesic medications variable or the number of pain-related medical visits.  
The overall results for this aspect of the analyses demonstrated that the associations 
between the background variables and important measures of patient functioning 
remained weak, and that the CPVI had robust negative associations, such that smaller 
discrepancies between values success and importance were associated with less disability, 
depression, and pain anxiety. 
Discussion	
 The present study used a CFA to examine the two-factor structure of the CAQ that was 
demonstrated in a prior principal components analysis (McCracken, 2013).  In addition to 
confirming the reliability of the items and factors that comprise the CAQ, the present 
analyses examined the degree to which the two latent factors of the CAQ were associated 
with measures of functioning relevant to chronic pain patients, including depression and 
pain-related anxiety.  Finally, a goal of the present study was to replicate the findings of the 
original investigation of the CAQ in a new sample of individuals with chronic pain.    
 Consistent with the prior study,25 the item-level analyses indicated that the CAQ 
performed well in the present sample of chronic pain patients. In particular, the results 
supported the internal consistency of the CAQ by demonstrating that the scale items were 
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sufficiently intercorrelated, without violating established guidelines regarding collinearity.  
Evidence of internal consistency suggests that the scale items point toward a common 
underlying construct 8, and the analyses produced a pattern of results similar to those of 
McCracken,25 which further supports the reliability of the CAQ.  Indeed, demonstrating 
reliability in multiple samples is an important component of measure development, as 
reliability is dependent on each administration of a measure.  Specific to clinical practice, 
the reliability of an instrument under consideration should be evaluated in multiple 
settings and with different samples of research participants drawn from a clinical 
population.  The results of the present study appear to support a preliminary position that 
the CAQ tends to produce reliable scores among pain patients in different chronic pain 
management settings. 
 In terms of factor structure, the present analyses also provided further evidence that 
the CAQ captures two processes related to committed action, values persistence (VP) and 
non-reactive behavior (NB).  The former involves working toward important goals, both 
with and without the presence of challenges and setbacks, and the latter involves a 
tendency to avoid actions that are inconsistent with the spirit of committed action.  Those 
who tend more toward VP and NB appear may be less likely, for example, to let impulsivity 
coordinate their actions.  Together, VP and NB constitute facets of the psychological 
flexibility model proposed by ACT, whereby VP involves pursuing valued activities both 
when it is easy and when challenges are encountered.  Further, psychological flexibility 
involves abandoning unworkable goals rather than rigidly adhering to them and 
determining alternative actions consistent with the identified value.24  The flexibility 
inherent in committed action may be an especially critical quality among chronic pain 
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patients, who often attempt to achieve meaningful behavioral targets in the service of 
improving in important areas of functioning while accepting that pain may not ever go 
away, i.e. pursuing values with or without pain.  The results of the CFA provided 
preliminary evidence in support of the theory that the CAQ assesses the two aspects of 
committed action, which concerns the construct validity of the CAQ in that the items are 
delineated topographically in a manner consistent with ACT principles. Although the chi-
square statistic was fairly large and statistically significant, the incremental and residual-
based fit indexes demonstrated adequate fit. Furthermore, the chi-square statistic derived 
from small samples may not actually follow the chi-square distribution, and thus the 
probability levels regarding overall model fit may not be accurate.35    
 Given the conceptual overlap between the item content in the CAQ, it was also 
important to examine the discriminant validity between the two factors.  More specifically, 
the factors in a CFA should be only moderately correlated, which suggests that the latent 
variables examined involve different constructs.21  With regard to the present analyses, the 
estimated factor correlation between VP and NB (r = .537) was indeed moderate in size and 
consistent with the hypothesis that the CAQ captures two separate latent variables. As 
expected, the association between the two subscales was positive.  
 The purpose of the regression analyses was to investigate incremental validity and 
determine whether the CAQ provided information relevant to assessment and treatment 
above and beyond a currently available instrument. In the first step of the regressions, 
without accounting for values discrepancy, the results confirmed that committed action 
may be a salient construct to measure when it comes to treating individuals with chronic 
pain, particularly in terms of both psychological distress and different facets of disability. 
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  With regard to examining the incremental validity of the CAQ, it was important to 
demonstrate significant direct effects after accounting for theoretically similar measures 
related to the psychological flexibility model in ACT.  In terms of the measures available for 
the current sample, a measure of values discrepancy (CPVI) appears to share properties 
with the CAQ, where both generally involve an assessment of success in pursuing valued 
activities.  Thus, including the CPVI in the simultaneous regressions could demonstrate the 
utility of using the CAQ in addition to the CPVI as part of clinical assessment. After 
accounting for variance that was explained by the CPVI, the overall pattern of significance 
for the CAQ subscales did change, such that the VP subscale dropped from significance for 
depression and for the psychosocial, physical and independence-related disability, though 
VP remained significant for pain distress and the number of pain-related medical visits. 
None of the direct effects for the NB factor, however, dropped from significance, with NB 
still having significant effects in the expected direction on all measures of psychological 
functioning examined, including measures of depression, pain anxiety, and pain distress, 
and on the three facets of disability.   
 In terms of limitations, the sample size should be considered small for a CFA.  
According to Kline,21 the ratio of cases to model parameters should be at least 10:1, or in 
absolute terms, at least N = 200.  In the present study, the number of estimated parameters 
was 137 and, given the sample size of 149, the ratio is just over 1:1. Thus the current 
sample size is somewhat smaller than what is recommended, and future research on the 
CAQ should replicate the analyses in the present study in a larger sample. An additional 
limitation pertains to the cross sectional nature of the study design, which does not allow 
for interpretations of causal effects of the CAQ factors on the measures of pain-related 
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functioning.  Future research efforts using this measure could employ longitudinal designs 
to explore whether committed action predicts change over time.   This could be 
accomplished, for instance, through the use of latent growth modeling, which can help 
advance the science of ACT processes by showing that committed action is a mechanism of 
change. 
The present study is part of a development process for use of the CAQ in clinical 
settings.  Future investigations of this instrument would benefit from a focus on chronic 
pain populations in other medical settings, such as those involved in outpatient treatment 
with interdisciplinary teams.  Further research should also investigate the CAQ with non-
pain populations as well, in accordance with the centrality of committed action to ACT in 
general. Also, with regard to the patterns of significance from the regressions, future 
studies of the CAQ could focus on exploring whether the NB subscale continues to 
outperform the VP subscale after accounting for values discrepancy. If future research 
demonstrates that the NB subscale consistently has more robust associations with 
important psychosocial outcomes in chronic pain management, its use may be justified as a 
standalone measure. Lastly, future studies of the CAQ in separate populations could 
consider expanding the analysis to potentially important covariates beyond the 
psychological flexibility model in ACT, such as self-efficacy and fear avoidance. Doing so 
would serve as an important step in testing the whether incremental validity of the CAQ 
extends to instruments outside the ACT framework. 
 Given that this is in part a measure development study, a consideration for further 
research involves assessing whether the factor structure of the CAQ is invariant, i.e. 
remains stable, across different subgroups within a sample. Examining the invariance of 
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the CAQ is an important step in determining that a measure is evaluating the same 
construct across groups and is a prerequisite for unambiguously interpreting between 
group differences on a measure.6  With a small overall sample in the present study, 
however, the power is inadequate to divide the participants into multiple groups to 
confirm measurement invariance. 
 Regarding the two-factor solution and discriminant validity, a final measurement 
development step for the CAQ might involve further analyses to confirm that the factors 
represent two meaningful and separate dimensions.  Again, using reverse-scored items 
(present on the NB subscale) within a measure may lead to the appearance of separate 
factors on the basis of wording effects.11, 33  Although the factors in the present study 
demonstrated sufficient discriminant validity, future research should investigate the 
possibility of a method effect from the negatively worded items. Perhaps the most 
straightforward means of examining the potential influence of wording effects would be to 
change the valence of the items in the NB subscale from negative to positive, administer the 
measure to a new sample, and retest the factor structure with CFA. 
 In summary, it appears that measuring committed action using the CAQ may be useful 
in predicting important outcomes related to functioning among chronic pain patients.  The 
results also provide evidence supporting the validity of the theory underlying committed 
action in ACT, namely that it involves the key components of persistence, flexibility, and 
non-reactive behavior in the pursuit of goals.  Ultimately, instruments like the CAQ may 
help researchers and clinicians understand the behaviors that lead to functional 
improvements in patients, including, but not necessarily limited to, those with chronic pain 
diagnoses.   
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Table	1.		Standardized	Factor	Loadings	for	Scale	Items	
 Factor  
Values Persistence Non-reactive Behavior 
Scale Item Factor Loading Scale Item Factor Loading	
Item 1 0.71	 Item 6 												0.60 
Item 2 0.76	 Item 9 												0.66 
Item 4 0.78	 Item 12 												0.59 
Item 5 0.79	 Item 14             0.44 
Item 7 0.76	 Item 17 												0.70 
Item 8 0.87	 Item 21 												0.72	
Item 15 0.74	 Item 22	             0.80	
Item 16 0.80	 Item 23	             0.62 
Item 19 0.69      
Note.		Standardized loadings that exceed .71, corresponding to a proportion of variance 
explained in the item by the factor > 50%, are bolded.  All p’s < .001.  
  
	 	
COMMITTED ACTION IN CHRONIC PAIN 
 
32 
Table	2.		Simultaneous	Multiple	Regression	Analyses	Predicting	Variance	in	Measures	of	
Health	Functioning	Scores	from	Demographic	and	Self‐Report	Measures	
	 SEM Model 1 - Without 
values discrepancy 
SEM Model 2 - With values 
discrepancy 
            Predictor	    β  S.E.	 			P    β	  S.E.	 			P	
Psychosocial	Disability	       
 Years of education .01 .08 .883 <.01 .08 .979 
 Pain duration .08 .08 .297   .11 .07 .122 
 Pain intensity .04 .07 .617   .02 .07 .780 
 Sex .09 .07 .229   .12 .07 .097 
 Values discrepancy    –     –        –        -.43    .08  <.001 
 Values Persistence  -.20 .09 .019 -.04 .09 .677 
 Non-reactive Behavior* -.42 .09 <.001 -.41 .09 <.001 
Physical	Disability	       
 Years of education  .01 .08   .888 <.01 .08   .970 
 Pain duration  .35 .07 <.001   .39 .07 <.001 
 Pain intensity  .07 .08   .316   .06 .07   .410 
 Sex -.11 .07   .145  -.09 .07   .216 
 Values discrepancy    – –      –     -.39    .08 <.001 
 Values Persistence -.19 .09 .029 -.04 .10 .701 
 Non-reactive Behavior* -.23 .10 .022 -.21 .10 .038 
Independence‐related	
Disability	       
 Years of education .02 .07   .753 .02 .07 .828 
 Pain duration .28 .08 <.001 .32 .07 <.001 
 Pain intensity .12 .07 .107 .11 .07 .140 
 Sex .11 .07 .110 .14 .07 .046 
 Values discrepancy    – –    – -.36    .08 <.001 
 Values Persistence  -.24 .09 .004 -.10 .09 .270 
 Non-reactive Behavior* -.28 .09 .002 -.27 .09 .004 
Depression		       
 Years of education .12 .11 .256 .12 .11 .260 
 Pain duration .10 .07 .163 .13 .07 .060 
 Pain intensity .04 .07 .527 .03 .07 .660 
 Sex .02 .07 .733 .05 .07 .486 
 Values discrepancy    –    –    – -.38 .07 <.001 
 Values Persistence  -.23 .08 .003 -.09 .08 .281 
 Non-reactive Behavior* -.52 .08 <.001 -.53 .08 <.001 
(table	continues)	
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Table	2	(continued)	
Pain	Anxiety	       
 Years of education .02 .08 .823 .01 .08 .852 
 Pain duration .07 .08 .367 .09 .09 .287 
 Pain intensity .18 .08 .024 .17 .08 .027 
 Sex .09 .07 .201 .11 .07 .139 
 Values discrepancy    – –      – -.21 .08 .013 
 Values Persistence -.12 .09 .183 -.04 .10 .694 
 Non-reactive Behavior* -.48 .09 <.001 -.47 .09 <.001 
Pain	distress	       
 Years of education -.03 .07 .648 -.04 .07 .633 
 Pain duration .02 .07 .808 .02 .07 .738 
 Pain intensity .49 .06 <.001 .50 .06 <.001 
 Sex -.05 .07 .451 -.04 .07 .509 
 Values discrepancy    – –    – -.10 .08 .232 
 Values Persistence  -.26 .08 .001 -.22 .09 .011 
 Non-reactive Behavior* -.22 .09 .013 -.21 .09 .017 
Number	of	pain‐related	
medical	visits	       
 Years of education -.14 .09 .148 -.14 .09 .136 
 Pain duration -.15 .10 .120 -.14 .10 .147 
 Pain intensity <-.01 .09 .985 <-.01 .09 .946 
 Sex -.13 .08 .122 -.12 .08 .140 
 Values discrepancy    –    –    – -.11 .10 .278 
 Values Persistence  -.27 .11 .011 -.23 .11 .039 
 Non-reactive Behavior* .01 .12 .907 .02 .12 .856 
Note.	Betas were standardized using the variances of the continuous latent variables as 
well as the variances of the outcome and covariate variables. 
*The items that comprise factor 2 were reverse scored prior to the data analyses 
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Appendix.		Committed	Action	Questionnaire	Item	Content*	
 
Directions:   Below you will find a list of statements.   Please rate the truth of each statement as it 
applies to you by circling a number.   Use the following rating scale to make your choices.   For 
instance, if you believe a statement is “Always True”, you would circle the 6 next to that statement. 
 
 
0	 1	 2	 3	 4	 5	 6	
Never Very	 Seldom	 Sometimes	 Often	 Almost	 Always	
True	 Rarely	 True True	 True	 Always	 True	
	 True 	 	 	 True	 	
 
1 I am able to persist with a course of action after 
experiencing difficulties 
 0 1 2 3 4 5 6 
2 When I fail in reaching a goal, I can change how I 
approach it 
 0 1 2 3 4 5 6 
4 I can remain committed to my goals even when there 
are times that I fail to reach them 
 0 1 2 3 4 5 6 
5 When a goal is difficult to reach, I am able to take 
small steps to reach it 
 0 1 2 3 4 5 6 
6 I act impulsively when I feel under pressure 
 
 0 1 2 3 4 5 6 
7 I prefer to change how I approach a goal rather than 
quit 
 
 
0 1 2 3 4 5 6 
8 I am able to follow my long terms plans including 
times when progress is slow 
 0 1 2 3 4 5 6 
 9 When I fail to achieve what I want to do, I make a 
point to never do that again 
 0 1 2 3 4 5 6 
11** I get stuck doing the same thing over and over even if 
I am not successful 
 0 1 2 3 4 5 6 
12 I find it difficult to carry on with an activity unless I 
experience that it is successful 
 0 1 2 3 4 5 6 
14 I am more likely to be guided by what I feel than by 
my goals 
 0 1 2 3 4 5 6 
15 I am able to pursue my goals both when this feels 
easy and when it feels difficult 
 0 1 2 3 4 5 6 
16 I am able to persist in what I am doing or to change 
what I am doing depending on what helps me reach 
my goals 
 
0 1 2 3 4 5 6 
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0	 1	 2	 3	 4	 5	 6	
Never Very	 Seldom	 Sometimes	 Often	 Almost	 Always	
True	 Rarely	 True True	 True	 Always	 True	
	 True 	 	 	 True	 	
 
17 If I make a commitment and later fail to reach it, I then 
drop the commitment 
 0 1 2 3 4 5 6 
19 I am able to incorporate discouraging experiences into the 
process of pursuing my long term plans 
 0 1 2 3 4 5 6 
21 If I feel distressed or discouraged, I let my commitments 
slide 
 0 1 2 3 4 5 6 
22 I get so wrapped up in what I am thinking or feeling that I 
cannot do the things that matter to me 
 0 1 2 3 4 5 6 
23 If I cannot do something my way, I will not do it at all 
 
 0 1 2 3 4 5 6 
 
Note:	
   *Item numbering is based on original 24-item measure from McCracken (2013) 
**	Item 11 dropped prior to the CFA analyses 
	
 
 
 
 
 
	
